Key Finding
BMSC-EVs significantly improved post-stroke cognitive function through region-specific hippocampal synaptic remodeling, with the dentate gyrus showing the most robust response via restoration of Sema3G-Nrp2/PlexinA4 signaling pathway.
Researchers investigated whether stem cell-derived particles called extracellular vesicles (EVs) could help restore memory and thinking abilities after stroke. Using a rat model of stroke, scientists administered bone marrow stem cell EVs through injections on days 1, 3, 5, and 7 after the stroke occurred. The results were promising: treated rats showed significant improvements in neurological function and cognitive abilities, including better performance on memory and spatial learning tests.
The study revealed that these EVs work by repairing damaged connections between brain cells, particularly in the hippocampus—the brain's memory center. Interestingly, different parts of the hippocampus responded differently to treatment. The dentate gyrus showed the most dramatic recovery, with increased connections between neurons and improved structural integrity. The CA3 region also demonstrated strong improvements in cell survival and synaptic connections, while the CA1 region showed more modest benefits.
The researchers identified a specific biological pathway (Sema3G-Nrp2/PlexinA4) that appears responsible for these healing effects. This pathway helps restore communication between blood vessels and nerve cells, which is crucial for brain repair after injury.
While this study focused on stem cell therapy rather than acupuncture, it's relevant to acupuncture patients because traditional Chinese medicine has long been used to support stroke recovery and cognitive function. Many practitioners integrate acupuncture with conventional rehabilitation to address post-stroke symptoms. The mechanisms identified in this research may overlap with some of acupuncture's neuroplastic effects, though more research is needed to establish direct connections. If considering acupuncture for stroke recovery, work with a licensed acupuncturist experienced in neurological rehabilitation.
This study investigated bone marrow mesenchymal stem cell-derived extracellular vesicles (BMSC-EVs) in transient middle cerebral artery occlusion (tMCAO) rat models. BMSC-EVs were administered intravenously at 24 hours post-reperfusion, with additional doses on days 3, 5, and 7. Behavioral assessments (mNSS, Morris Water Maze, Y-maze) demonstrated significant improvements in neurological and cognitive function (P<0.05). Histological analyses revealed region-specific synaptic remodeling in hippocampal subregions: dentate gyrus showed increased spine density beyond sham levels (P<0.01) with mature spine morphology and enhanced NF200 expression (P<0.001); CA3 exhibited improved neuronal survival (P<0.05) and elevated Syn/PSD-95 expression (P<0.01, P<0.001); CA1 showed limited structural recovery despite moderate increases in synaptic proteins (P<0.001). Mechanistically, BMSC-EVs restored ischemia-induced downregulation of Sema3G, Nrp2, and PlexinA4 (P<0.05 to P<0.001), suggesting activation of neurovascular signaling crucial for synaptic remodeling. Clinical takeaway: Region-specific hippocampal responses may inform targeted therapeutic strategies for post-stroke cognitive rehabilitation.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.